Clinical characteristics & outcome of acute heart failure in Korea: Results from the Korean acute heart failure registry (KorAHF)

Korean Circulation Journal

Volumn 47, Issue 3, 2017, Pages 341-353

  Lee, Sang Eun ^a   Lee, Hae Young ^a   Cho, Hyun Jai ^a   Choe, Won Seok ^a   Kim, Hokon ^a   Choi, Jin Oh ^b   Jeon, Eun Seok ^b   Kim, Min Seok ^c   Kim, Jae Joong ^c   Hwang, Kyung Kuk ^d   Chae, Shung Chull ^e   Baek, Sang Hong ^f   Kang, Seok Min ^g   Choi, Dong Ju ^h   Yoo, Byung Su ⁱ   Kim, Kye Hun ^j   Park, Hyun Young ^k   Cho, Myeong Chan ^d   Oh, Byung Hee ^a  

^a Seoul National University Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Chungbuk National University College of Medicine   (South Korea)

^e Kyungpook National University School of Medicine   (South Korea)

^f The Catholic University of Korea College of Medicine   (South Korea)

^g Yonsei University College of Medicine   (South Korea)

^h Seoul National University Bundang Hospital   (South Korea)

ⁱ Yonsei University Wonju College of Medicine   (South Korea)

^j Chonnam National University   (South Korea)

^k Korea National Institute of Health   (South Korea)

more..

Author keywords

Acute heart failure; Guideline adherence; Heart failure; Mortality; Quality of health care; Treatment outcome

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT; LOOP DIURETIC AGENT; VASODILATOR AGENT; WARFARIN;

ACUTE HEART FAILURE; ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DISEASE REGISTRY; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; HOSPITAL PATIENT; HUMAN; ISCHEMIA; KOREA; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRESCRIPTION; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 85020170387     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2016.0419     Document Type: Article

References (28)

1. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011;8:30-41.
2. Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014;63:1123-33.
3. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation 2011;123:933-44.
4. Okura Y, Ramadan MM, Ohno Y, et al. Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J 2008;72:489-91.
5. Curtis LH, Whellan DJ, Hammill BG, et al. Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med 2008;168:418-24.
6. Sato N, Kajimoto K, Asai K, et al. Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: Rationale, design, and preliminary data. Am Heart J 2010;159:949-55.e1.
7. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW; ADHERE Scientific Advisory Committee and Investigators. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2007;153:1021-8.
8. Abraham WT, Fonarow GC, Albert NM, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 2008;52:347-56.
9. Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey II (EHFS II): A survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006;27:2725-36.
10. West R, Liang L, Fonarow GC, et al. Characterization of heart failure patients with preserved ejection fraction: A comparison between ADHERE-US registry and ADHERE-International registry. Eur J Heart Fail 2011;13:945-52.
11. Choi DJ, Han S, Jeon ES, et al. Characteristics, outcomes and predictors of long-Term mortality for patients hospitalized for acute heart failure: A report from the korean heart failure registry. Korean Circ J 2011;41:363-71.
12. Francis GS, Cogswell R, Thenappan T. The heterogeneity of heart failure: Will enhanced phenotyping be necessary for future clinical trial success? J Am Coll Cardiol 2014;64:1775-6.
13. Pitt B, Pfeffer MA, Assmann SF, et al. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014;370:1383-92.
14. Kook HY, Jeong MH, Oh S, et al. Current trend of acute myocardial infarction in Korea (from the Korea Acute Myocardial Infarction Registry from 2006 to 2013). Am J Cardiol 2014;114:1817-22.
15. Ha KH, Kim DJ. Trends in the diabetes epidemic in Korea. Endocrinol Metab (Seoul) 2015;30:142-6.
16. Jhun HJ, Kim H, Cho SI. Time trend and age-period-cohort effects on acute myocardial infarction mortality in Korean adults from 1988 to 2007. J Korean Med Sci 2011;26:637-41.
17. Lee JH, Lim NK, Cho MC, Park HY. Epidemiology of heart failure in Korea: present and future. Korean Circ J 2016;46:658-64.
18. Service KNHI [Internet]. 2014 Sep [cited 2016 October]. Available from: http://www.nhis.or.kr/bbs7/boards/B0039/3171.
19. Han SW, Ryu KH, Chae SC, et al. Multicenter analysis of clinical characteristics and prognostic factors of patients with congestive heart failure in Korea. Korean Circ J 2005;35:357-61.
20. Lee SE, Cho HJ, Lee HY, et al. A multicentre cohort study of acute heart failure syndromes in Korea: Rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry. Eur J Heart Fail 2014;16:700-8.
21. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129-200.
22. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-16.
23. Harjola VP, Follath F, Nieminen MS, et al. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail 2010;12:239-48.
24. Chioncel O, Vinereanu D, Datcu M, et al. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry. Am Heart J 2011;162:142-53. e1.
25. McCullough PA, Hassan SA, Pallekonda V, et al. Bundle branch block patterns, age, renal dysfunction, and heart failure mortality. Int J Cardiol 2005;102:303-8.
26. Farwell D, Patel NR, Hall A, Ralph S, Sulke AN. How many people with heart failure are appropriate for biventricular resynchronization? Eur Heart J 2000;21:1246-50.
27. Maggioni AP, Anker SD, Dahlström U, et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12, 440 patients of the ESC heart failure long-Term registry. Eur J Heart Fail 2013;15:1173-84.
28. Lee HY, Chung WJ, Jeon HK, et al. Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: Association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study. Korean J Intern Med 2016;31:277-87.